Entering text into the input field will update the search result below

This High Yielding Energy Concern Is Getting Cheap

May 08, 2012 12:30 PM ETEquinor ASA (EQNR) Stock12 Comments

It is an ugly day in the market as the market finally reacts to the unfolding crisis in Greece and the ramifications for the European continent. Oil continues to take it in the shorts and the pain in the energy sector continues. However, some real bargains are starting to become available for long term investors. One stock that reported earnings today, Statoil (STO), looks like a compelling value here, especially for investors who want low valuations, growing production and a high dividend yield.

Key Highlights from Statoil earnings report

  • Production was up 11% Y/Y.
  • Earnings were down only because last year's first-quarter earnings were boosted by the sale of a 40-percent stake in the Kai Kos Dehseh oil sands project and higher taxes this quarter.
  • Statoil said it aims to reach an equity production above 2.5 million barrels of oil equivalent in 2020 as new projects come on stream


Statoil - "Statoil ASA, an integrated energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and petroleum-derived products in Norway and internationally". (Business Description from Yahoo Finance)

4 reasons STO has long term value at just over still $25 a share:

  • The stock is yielding 3.7% and has a payout ratio of around 30%.
  • Consensus earnings estimates for FY2012 and FY2013 have risen solidly over the past two months.
  • The stock is cheap given its dividend yield at around 8 times forward earnings and a five year projected PEG of just over 1 (1.14).
  • The five analysts that cover the stock have a median target of $30 on Statoil. It also just completed a very smart deal with Russia on a massive exploration opportunity there.

Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in STO over the next 72

This article was written by

Bret Jensen profile picture
48.72K Followers

Bret Jensen has over 13 years as a market analyst, helping investors find big winners in the biotech sector. Bret specializes in high beta sectors with potentially large investor returns.

Bret leads the investing group The Biotech Forum, in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More.

Recommended For You

About EQNR Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

More on EQNR

Related Stocks

SymbolLast Price% Chg
EQNR
--